menu search

Azure biotech announces educational initiative to create awareness of unmet women’s menopausal medical issue

vulvovaginal Atrophy (VVA), also known as the Genitourinary Syndrome of Menopause (GSM), affects over 3...

August 30, 2023, 4:55 pm

Scynexis: licensing deal with gsk, upgrading to a hold rating from a sell

GSK and SCYNEXIS signed an exclusive licensing agreement for Brexafemme, an FDA-approved medicine for vulvovag...

March 31, 2023, 11:47 am

Why is scynexis (scyx) stock up 69% today?

Scynexis (NASDAQ: SCYX ) stock is taking off on Tuesday as investors react to news of an exclusive license agreement for Brexafemme. Brexafemme is an ...

March 30, 2023, 10:26 am

vulvovaginal candidiasis treatment market is likely to witness steady growth, anticipated to reach us$ 1607 million by 2033: future market insights, inc.

The vulvovaginal candidiasis treatment market is exploding, expected to skyrocket from its current US$1...

January 17, 2023, 5:30 am


Search within

Pages Search Results: